03.06.2013 Views

Registration document 2007 - Total.com

Registration document 2007 - Total.com

Registration document 2007 - Total.com

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(iii) Portion of intangible assets amortization related to the<br />

Sanofi-Aventis merger<br />

The detail of these adjustment items is presented in note 4 to the<br />

consolidated financial statements.<br />

Operating in<strong>com</strong>e (measure used to evaluate operating<br />

performance)<br />

Revenue from sales after deducting cost of goods sold and<br />

inventory variations, other operating expenses, exploration<br />

expenses and depreciation, depletion, and amortization.<br />

Operating in<strong>com</strong>e excludes the amortization and depreciation of<br />

intangible assets other than leasehold rights, currency translation<br />

adjustments and gains or losses on the sale of assets.<br />

Net operating in<strong>com</strong>e (measure used to evaluate the<br />

return on capital employed)<br />

Operating in<strong>com</strong>e after deducting the amortization and the<br />

depreciation of intangible assets other than leasehold rights,<br />

currency translation adjustments and gains or losses on the sale<br />

of assets, as well as all other in<strong>com</strong>e and expenses related to<br />

capital employed (dividends from non-consolidated <strong>com</strong>panies,<br />

equity in in<strong>com</strong>e in affiliates, capitalized interest expenses), and<br />

after in<strong>com</strong>e taxes applicable to the above.<br />

The in<strong>com</strong>e and expense not included in net operating in<strong>com</strong>e<br />

which are included in net in<strong>com</strong>e are only interest expenses<br />

related to non-current liabilities net of interest earned on cash<br />

and cash equivalents, after applicable in<strong>com</strong>e taxes (net cost of<br />

net debt and minority interests).<br />

Adjusted in<strong>com</strong>e<br />

Operating in<strong>com</strong>e, net operating in<strong>com</strong>e, or net in<strong>com</strong>e<br />

excluding the effect of adjusting items described above.<br />

Capital employed<br />

Non-current assets and working capital requirements, at<br />

replacement cost, net of deferred in<strong>com</strong>e taxes and non-current<br />

liabilities.<br />

ROACE (Return on Average Capital Employed)<br />

Ratio of adjusted net operating in<strong>com</strong>e to average capital<br />

employed between the beginning and the end of the period.<br />

Net debt<br />

Non-current debt, including current portion, current borrowings,<br />

other current financial liabilities less cash and cash equivalent and<br />

other current financial assets.<br />

Appendix 1 – Consolidated financial statements<br />

Notes to the consolidated financial statement<br />

3) Changes in the Group structure, main acquisitions<br />

and divestitures<br />

2006<br />

After approval on October 13, 2006 by the European<br />

Commission, Banco Santander Central Hispano (Santander) sold<br />

4.35% of CEPSA’s share capital to TOTAL at a price of 4.54<br />

euros per share, for a total transaction amount of approximately<br />

53 M€. The transaction follows the agreement signed on August<br />

2, 2006 by TOTAL and Santander to implement the provisions of<br />

the partial award rendered on March 24, 2006 by the<br />

Netherlands Arbitration Institute, which adjudicated the dispute<br />

concerning CEPSA.<br />

As a result TOTAL now holds 48.83% of CEPSA.<br />

In 2004, TOTAL announced a reorganization of its Chemical<br />

segment to regroup its chlorochemicals, intermediates and<br />

performance polymers in a new entity that was named Arkema<br />

on October 1, 2004.<br />

The Shareholders’ meeting on May 12, 2006 approved a<br />

resolution related to the spin-off of Arkema and the distribution of<br />

Arkema shares to TOTAL shareholders. Pursuant to this<br />

approval, Arkema shares were publicly listed on May 18, 2006 on<br />

the Eurolist by Euronext market in Paris. For all periods<br />

presented, the contribution of Arkema entities to the consolidated<br />

net in<strong>com</strong>e is presented on the line “Consolidated net in<strong>com</strong>e<br />

from discontinued operations” on the face of the in<strong>com</strong>e<br />

statement. Detailed information on the impact of this transaction<br />

is presented in the note 32 to the consolidated financial<br />

statements.<br />

2005<br />

Pursuant to its public offer and takeover bid circular dated<br />

August 5, 2005 and extended to September 2, 2005, TOTAL has<br />

acquired 78% of Deer Creek Energy Ltd as of September 13,<br />

2005. Its offer was extended in order to acquire the shares which<br />

had not been tendered. The acquisition of all ordinary shares was<br />

<strong>com</strong>pleted on December 13, 2005.<br />

Deer Creek Energy Ltd has an 84% interest in the Joslyn permit<br />

in the Athabasca region of the Canadian province of Alberta.<br />

The acquisition cost, net of cash acquired (0.1 B€) for all shares<br />

amounts to 1.1 B€. This cost essentially represents the value of<br />

the <strong>com</strong>pany’s leasehold rights that have been recognized as<br />

intangible assets on the face of the consolidated balance sheet<br />

for 1 B€.<br />

Deer Creek Energy Ltd is fully consolidated in TOTAL’s<br />

consolidated financial statements. Its contribution to 2005<br />

consolidated net in<strong>com</strong>e is not material.<br />

9<br />

2004<br />

Following the out<strong>com</strong>e of a share and cash offer by<br />

Sanofi-Synthélabo on Aventis in 2004, the merger via takeover of<br />

Aventis, thereby creating the entity Sanofi-Aventis, was approved<br />

TOTAL – <strong>Registration</strong> Document 2006 181

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!